Back to TCRX
UBS Group AG TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$34K
Q3 2026
Peak value
$55K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $18K |
| Q3 2025 | $2K |
| Q4 2025 | $55K |
| Q4 2025 | $58 |
| Q1 2026 | $7K |
| Q1 2026 | $25K |
| Q2 2026 | $54K |
| Q2 2026 | $27 |
| Q2 2026 | $13K |
| Q3 2026 | $34K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34K | 108.2K | — | — |
| Q2 2026 | $13K | 13.6K | — | — |
| Q2 2026 | $27 | 28 | — | — |
| Q2 2026 | $54K | 55.3K | — | — |
| Q1 2026 | $25K | 25.1K | — | — |
| Q1 2026 | $7K | 7.4K | — | — |
| Q4 2025 | $58 | 58 | — | — |
| Q4 2025 | $55K | 55.1K | — | — |
| Q3 2025 | $2K | 1.3K | — | — |
| Q3 2025 | $18K | 9.7K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M